Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Progressive Telomere Shortening Is Part of the Natural History of Chronic Lymphocytic Leukemia (CLL) and Impacts Clinical Outcome

Blood (2011) 118 (21): 2845.

https://doi.org/10.1182/blood.V118.21.2845.2845

Published: 2011

Journal Articles

CD38 Induces Homing of Chronic Lymphocytic Leukemia Cells to the Lymphoid Organs through a Functional Interplay with CXCR4.

Silvia Deaglio, MD, PhD, Semra Aydin, MD, Tiziana Vaisitti, PhD, Luciana Bergui, MD, PhD, Davide Rossi, MD, Giovanni D'Arena, MD, Lisa Bonello, PhD, Maurizia Mello Grand, PhD, Giovanna Chiorino, Alberto Horenstein, PhD, Gianluca Gaidano, MD, PhD, Fabio Malavasi, MD

Blood (2009) 114 (22): 2328.

https://doi.org/10.1182/blood.V114.22.2328.2328

Published: 2009

Journal Articles

Dexamethasone, Cytarabine and Cisplatin or Oxaliplatin Schedule (DHAP or Ox-DHA) Is Effective and Widely Applicable in Chronic Lymphocytic Leukemia and Waldenström Macroglobulinemia.

Marco Ruella, MD, Irene Ricca, MD, Angela Gueli, MD, Daniela Gottardi, MD, Daniele Caracciolo, MD, Luciana Bergui, MD, Paolo Gavarotti, MD, Alberto De Crescenzo, MD, Lucia Farina, Paolo Corradini, MD, Corrado Tarella, MD

Blood (2009) 114 (22): 3434.

https://doi.org/10.1182/blood.V114.22.3434.3434

Published: 2009

Journal Articles

Telomere Length Is An Independent Predictor of Survival, Treatment Requirement and Richter’s Syndrome Transformation in Chronic Lymphocytic Leukemia.

Blood (2008) 112 (11): 1052.

https://doi.org/10.1182/blood.V112.11.1052.1052

Published: 2008

Journal Articles

Human CD38 Is a Potential Therapeutic Target for Sekected Chronic Lymphocytic Leukemia cases.

Silvia Deaglio, Semra Aydin, Tiziana Vaisitti, Luciana Bergui, Giovanni D’Arena, Lisa Bonello, Ifigenia Saborit, Davide Rossi, Gianluca Gaidano, Giovanna Chiorino, Fabio Malavasi

Blood (2008) 112 (11): 2096.

https://doi.org/10.1182/blood.V112.11.2096.2096

Published: 2008

Journal Articles

CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome?

Semra Aydin, Davide Rossi, Luciana Bergui, Giovanni D'Arena, Enza Ferrero, Lisa Bonello, Paola Omedé, Domenico Novero, Fortunato Morabito, Antonino Carbone, Gianluca Gaidano, Fabio Malavasi, Silvia Deaglio

Blood (2008) 111 (12): 5646–5653.

https://doi.org/10.1182/blood-2008-01-129726

Published: 2008

Journal Articles

CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential

Silvia Deaglio, Tiziana Vaisitti, Semra Aydin, Luciana Bergui, Giovanni D'Arena, Lisa Bonello, Paola Omedé, Maria Scatolini, Ozren Jaksic, Giovanna Chiorino, Dimitar Efremov, Fabio Malavasi

Blood (2007) 110 (12): 4012–4021.

https://doi.org/10.1182/blood-2007-06-094029

Published: 2007

Journal Articles

Non-Hodgkin’s Lymphoma Refractory to First Line Therapy: Incidence, Associated Clinical and Histological Factors, and Outcome among 503 Newly Diagnosed Patients.

Angela Gueli, MD, Daniele Caracciolo, MD, Manuela Zanni, MD, Luciana Bergui, MD, Paolo Gavarotti, MD, Marco Ladetto, MD, Andrea Filippi, MD, Roberto Passera, PhD, Mario Boccadoro, MD, Corrado Tarella, MD

Blood (2007) 110 (11): 1373.

https://doi.org/10.1182/blood.V110.11.1373.1373

Published: 2007

Journal Articles

CD38 and ZAP-70 Mark Chronic Lymphocytic Leukemia (CLL) Cells with High Migratory Potential and Regulate Chemotaxis.

Silvia Deaglio, MD, PhD, Semra Aydin, M.D., Tiziana Vaisitti, Ph.D., Luciana Bergui, M.D., Giovanni D’Arena, M.D., Lisa Bonello, Ph.D, Paola Omedé, Ph.D., Giovanna Chiorino, Ph.D, Dimitar Efremov, M.D., Fabio Malavasi, M.D.

Blood (2007) 110 (11): 4684.

https://doi.org/10.1182/blood.V110.11.4684.4684

Published: 2007

Journal Articles

CD38/CD19: a lipid raft–dependent signaling complex in human B cells

Silvia Deaglio, Tiziana Vaisitti, Richard Billington, Luciana Bergui, Paola Omede', Armando A. Genazzani, Fabio Malavasi

Blood (2007) 109 (12): 5390–5398.

https://doi.org/10.1182/blood-2006-12-061812

Published: 2007

Journal Articles

Telomere Length Identifies Two Distinct Populations with Different Outcome among VH-Unmutated CLL Patients.

Irene Ricca, MD, Alberto Rocci, MD, Daniela Drandi, PhD, Mara Compagno, PhD, Roberto Francese, PhD, Paola Omedè, PhD, Loredana Santo, MD, Michela Rosace, PhD, Federica De Marco, MD, Monica Astolfi, PhD, Chiara Lobetti Bodoni, MD, Maria Dell’Aquila, PhD, Sonia Vallet, MD, Luciana Bergui, MD, Andrea Gallamini, MD, Carlo Marinone, MD, Mario Boccadoro, MD, Corrado Tarella, MD, Marco Ladetto, MD

Blood (2005) 106 (11): 2104.

https://doi.org/10.1182/blood.V106.11.2104.2104

Published: 2005

Journal Articles

CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival

Silvia Deaglio, Tiziana Vaisitti, Luciana Bergui, Lisa Bonello, Alberto L. Horenstein, Luca Tamagnone, Laurence Boumsell, Fabio Malavasi

Blood (2005) 105 (8): 3042–3050.

https://doi.org/10.1182/blood-2004-10-3873

Published: 2005

Journal Articles

Incidence and Risk-Factors of Secondary Myelodysplastic Syndrome/Acute Leukemia Following High-Dose Chemotherapy and Autograft: A Long-Term Analysis on 307 Lymphoma Patients.

Davide Bono, MD, Manuela Zanni, MD, Irene Ricca, MD, Daniele Caracciolo, MD, Elisa Dama, MD, Corrado Magnani, MD, Paolo Gavarotti, MD, Luciana Bergui, MD, Alessandra Cuttica, MD, Marco Ladetto, MD, Mario Boccadoro, MD, Dario Ferrero, MD, Corrado Tarella, MD

Blood (2004) 104 (11): 2248.

https://doi.org/10.1182/blood.V104.11.2248.2248

Published: 2004

Journal Articles

Telomere Length Has Prognostic Impact in B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Irene Ricca, MD, Daniela Drandi, PhD, Alberto Rocci, MD, Mara Compagno, PhD, Roberto Francese, PhD, Barbara Mantoan, PhD, Claudia Castellino, MD, Francesca Ficara, MD, Sonia Vallet, MDD, Maria Dell’Aquila, PhD, Loredana Santo, MD, Daniele Caracciolo, MD, Luciana Bergui, MD, Andrea Gallamini, MD, Mario Bazzan, MD, Carlo Marinone, MD, Mario Boccadoro, MD, Corrado Tarella, MD, Marco Ladetto, MD

Blood (2004) 104 (11): 4768.

https://doi.org/10.1182/blood.V104.11.4768.4768

Published: 2004

Journal Articles

CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells

Silvia Deaglio, Andrea Capobianco, Luciana Bergui, Jan Dürig, Fortunato Morabito, Ulrich Dührsen, Fabio Malavasi

Blood (2003) 102 (6): 2146–2155.

https://doi.org/10.1182/blood-2003-03-0989

Published: 2003

NARROW

Progressive Telomere Shortening Is Part of the Natural History of Chronic Lymphocytic Leukemia (CLL) and Impacts Clinical Outcome

CD38 Induces Homing of Chronic Lymphocytic Leukemia Cells to the Lymphoid Organs through a Functional Interplay with CXCR4.

Dexamethasone, Cytarabine and Cisplatin or Oxaliplatin Schedule (DHAP or Ox-DHA) Is Effective and Widely Applicable in Chronic Lymphocytic Leukemia and Waldenström Macroglobulinemia.

Telomere Length Is An Independent Predictor of Survival, Treatment Requirement and Richter’s Syndrome Transformation in Chronic Lymphocytic Leukemia.

Human CD38 Is a Potential Therapeutic Target for Sekected Chronic Lymphocytic Leukemia cases.

CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome?

CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential

Non-Hodgkin’s Lymphoma Refractory to First Line Therapy: Incidence, Associated Clinical and Histological Factors, and Outcome among 503 Newly Diagnosed Patients.

CD38 and ZAP-70 Mark Chronic Lymphocytic Leukemia (CLL) Cells with High Migratory Potential and Regulate Chemotaxis.

CD38/CD19: a lipid raft–dependent signaling complex in human B cells

Telomere Length Identifies Two Distinct Populations with Different Outcome among VH-Unmutated CLL Patients.

CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival

Incidence and Risk-Factors of Secondary Myelodysplastic Syndrome/Acute Leukemia Following High-Dose Chemotherapy and Autograft: A Long-Term Analysis on 307 Lymphoma Patients.

Telomere Length Has Prognostic Impact in B-Cell Chronic Lymphocytic Leukemia (B-CLL).

CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only